StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)

Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –

Nephros price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nephros's price to sales ratio was 1.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.9× to 6.1×, with a median of 1.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−1.3
2025Dec 31, 20252.9×+1.7
2024Dec 31, 20241.1×−1.5
2023Dec 29, 20232.7×+1.5
2022Dec 30, 20221.2×−4.9
2021Dec 31, 20216.1×−2.2
2020Dec 31, 20208.3×−0.6
2019Dec 31, 20198.8×+2.0
2018Dec 31, 20186.8×−0.7
2017Dec 29, 20177.5×−1.8
2016Dec 30, 20169.3×+5.6
2015Dec 31, 20153.7×−8.6
2014Dec 31, 201412.2×+8.2
2013Dec 31, 20134.0×−3.2
2012Dec 31, 20127.2×+4.1
2011Dec 30, 20113.1×–

More Nephros figures

See a number that looks wrong?